165 related articles for article (PubMed ID: 16425945)
1. Ezetimibe: a turbocharger for the race to reach NCEP LDL goals.
Lee S
S D J Med; 2005 Oct; 58(10):435-6. PubMed ID: 16425945
[No Abstract] [Full Text] [Related]
2. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
Pearson TA; Denke MA; McBride PE; Battisti WP; Brady WE; Palmisano J
Mayo Clin Proc; 2005 May; 80(5):587-95. PubMed ID: 15887425
[TBL] [Abstract][Full Text] [Related]
3. Getting there: statin plus ezetimibe for low-density lipoprotein cholesterol goals.
Hurley DL; Isley WL
Mayo Clin Proc; 2005 May; 80(5):585-6. PubMed ID: 15887424
[No Abstract] [Full Text] [Related]
4. Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors.
Chuang P; Langone AJ
Am J Ther; 2007; 14(5):438-41. PubMed ID: 17890931
[TBL] [Abstract][Full Text] [Related]
5. LDL = 5: Virtues and dangers of multidrug therapy of low-density lipoprotein cholesterol.
Phillips W; Schaefer S
Prev Cardiol; 2010; 13(2):69-71. PubMed ID: 20377808
[TBL] [Abstract][Full Text] [Related]
6. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
Daskalopoulou SS; Mikhailidis DP
Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe offers new opportunity to lower LDL-C to target levels.
Cardiovasc J S Afr; 2005; 16(3):174. PubMed ID: 16049593
[No Abstract] [Full Text] [Related]
8. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
Hou R; Goldberg AC
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
[TBL] [Abstract][Full Text] [Related]
9. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
10. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
[No Abstract] [Full Text] [Related]
11. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
12. LDL reduction: how low should we go and is it safe?
Robinson JG
Curr Cardiol Rep; 2008 Nov; 10(6):481-7. PubMed ID: 18950559
[TBL] [Abstract][Full Text] [Related]
13. Zetia (ezetimibe).
Kloner RA
Congest Heart Fail; 2003; 9(2):109-10. PubMed ID: 12671344
[No Abstract] [Full Text] [Related]
14. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
[No Abstract] [Full Text] [Related]
15. Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence.
Mascitelli L; Pezzetta F; Goldstein MR
Arch Med Res; 2010 Nov; 41(8):649-50. PubMed ID: 21199735
[TBL] [Abstract][Full Text] [Related]
16. Rationale for aggressive lipid lowering in high-risk patients.
Cohen JD
J Am Osteopath Assoc; 2011 Apr; 111(4 Suppl 3):eS7-12. PubMed ID: 21593473
[TBL] [Abstract][Full Text] [Related]
17. Niacin compared with ezetimibe.
Duivenvoorden R; Vergeer M; Kastelein JJ
N Engl J Med; 2010 Mar; 362(11):1046-7; author reply 1048. PubMed ID: 20301795
[No Abstract] [Full Text] [Related]
18. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
19. Is there a problem with ezetimibe or just ENHANCEd hype?
Whayne TF
Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
[No Abstract] [Full Text] [Related]
20. Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption.
Bruckert E; Giral P; Tellier P
Circulation; 2003 Jul; 107(25):3124-8. PubMed ID: 12835406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
